SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Ahmed Z, Smith BJ, Pillay TS. 2000. The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett 475(1): 3134.
  • Ahn MY, Katsanakis KD, Bheda F, Pillay TS. 2004. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J Biol Chem 279(20): 2152621532.
  • Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22(24): 66536664.
  • Alber T. 1992. Structure of the leucine zipper. Curr Opin Genet Dev 2(2): 227235.
  • Altun-Gultekin ZF, Chandriani S, Bougeret C, Ishizaki T, Narumiya S, de Graaf P, Van Bergen en Henegouwen P, Hanafusa H, Wagner JA, Birge RB. 1998. Activation of Rho-dependent cell spreading and focal adhesion biogenesis by the v-Crk adaptor protein. Mol Cell Biol 18(5): 30443058.
  • Amsen D, Kruisbeek A, Bos JL, Reedquist K. 2000. Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection. Eur J Immunol 30(10): 28322841.
  • Andoniou CE, Thien CB, Langdon WY. 1994. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J 13(19): 45154523.
  • Andoniou CE, Thien CB, Langdon WY. 1996. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene 12(9): 19811989.
  • Andoniou CE, Lill NL, Thien CB, Lupher ML, Jr., Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H. 2000. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol Cell Biol 20(3): 851867.
  • Arthur WT, Quilliam LA, Cooper JA. 2004. Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors. J Cell Biol 167(1): 111122.
  • Auger JM, Best D, Snell DC, Wilde JI, Watson SP. 2003. c-Cbl negatively regulates platelet activation by glycoprotein VI. J Thromb Haemost 1(11): 24192426.
  • Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, Oliveira-dos-Santos A, Mariathasan S, Bouchard D, Wakeham A, Itie A, Le J, Ohashi PS, Sarosi I, Nishina H, Lipkowitz S, Penninger JM. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403(6766): 211216.
  • Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J, Yarden Y. 2000. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J Biol Chem 275(34): 2617826186.
  • Bao J, Gur G, Yarden Y. 2003. Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors. Proc Natl Acad Sci USA 100(5): 24382443.
  • Bartkiewicz M, Houghton A, Baron R. 1999. Leucine zipper-mediated homodimerization of the adaptor protein c-Cbl. A role in c-Cbl's tyrosine phosphorylation and its association with epidermal growth factor receptor. J Biol Chem 274(43): 3088730895.
  • Batzer AG, Rotin D, Urena JM, Skolnik EY, Schlessinger J. 1994. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14(8): 51925201.
  • Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. 2000. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407(6801): 202207.
  • Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA. 2003. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. Eur J Biochem 270(19): 38913903.
  • Bennett AM, Tang TL, Sugimoto S, Walsh CT, Neel BG. 1994. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. Proc Natl Acad Sci USA 91(15): 73357339.
  • Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F. 2005. CBLB variants in type 1 diabetes and their genetic interaction with CTLA4. J Leukoc Biol 77(4): 579585.
  • Bertolaet BL, Clarke DJ, Wolff M, Watson MH, Henze M, Divita G, Reed SI. 2001. UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat Struct Biol 8(5): 417422.
  • Bisson SA, Ujack EE, Robbins SM. 2002. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line. Oncogene 21(23): 36773687.
  • Blake TJ, Shapiro M, Morse HCd, Langdon WY. 1991. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6(4): 653657.
  • Bonita DP, Miyake S, Lupher ML, Jr., Langdon WY, Band H. 1997. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: Implications for Cbl's function and oncogenicity. Mol Cell Biol 17(8): 45974610.
  • Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. 1997. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1. Science 278(5335): 124128.
  • Bowtell DD, Langdon WY. 1995. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene 11(8): 15611567.
  • Braun L, Ghebrehiwet B, Cossart P. 2000. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J 19(7): 14581466.
  • Brenner B, Kadel S, Birle A, Linderkamp O. 2001. L-selectin tyrosine phosphorylates cbl and induces association of tyrosine-phosphorylated cbl with crkl and grb2. Biochem Biophys Res Commun 282(1): 4147.
  • Brizzi MF, Rosso A, Dentelli P, Ferrero D, Lanfrancone L, Pegoraro L. 1998. c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells. Exp Hematol 26(13): 12291239.
  • Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, Tosello-Trampont AC, Macara IG, Madhani H, Fink GR, Ravichandran KS. 2002. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 4(8): 574582.
  • Bruzzaniti A, Neff L, Sanjay A, Horne WC, De Camilli P, Baron R. 2005. Dynamin forms a Src-kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol Biol Cell 16: 33013313.
  • Burridge K, Wennerberg K. 2004. Rho and Rac take center stage. Cell 116(2): 167179.
  • Busch SJ, Sassone-Corsi P. 1990. Dimers, leucine zippers and DNA-binding domains. Trends Genet 6(2): 3640.
  • Bustelo XR. 2002. Regulation of Vav proteins by intramolecular events. Front Biosci 7: d24d30.
  • Bustelo XR, Crespo P, Lopez-Barahona M, Gutkind JS, Barbacid M. 1997. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene 15(21): 25112520.
  • Carpino N, Turner S, Mekala D, Takahashi Y, Zang H, Geiger TL, Doherty P, Ihle JN. 2004. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20(1): 3746.
  • Caveggion E, Continolo S, Pixley FJ, Stanley ER, Bowtell DD, Lowell CA, Berton G. 2003. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J Cell Physiol 195(2): 276289.
  • Chen L, Shinde U, Ortolan TG, Madura K. 2001. Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep 2(10): 933938.
  • Chernock RD, Cherla RP, Ganju RK. 2001. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood 97(3): 608615.
  • Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ, Jang IK, Gutkind JS, Shevach E, Gu H. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403(6766): 216220.
  • Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, Saltiel AR. 2001. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410(6831): 944948.
  • Chiusaroli R, Sanjay A, Henriksen K, Engsig MT, Horne WC, Gu H, Baron R. 2003. Deletion of the gene encoding c-Cbl alters the ability of osteoclasts to migrate, delaying resorption and ossification of cartilage during the development of long bones. Dev Biol 261(2): 537547.
  • Cho SY, Klemke RL. 2000. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 149(1): 223236.
  • Cho SY, Klemke RL. 2002. Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J Cell Biol 156(4): 725736.
  • Cote JF, Vuori K. 2002. Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity. J Cell Sci 115(Pt 24): 49014913.
  • Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385(6612): 169172.
  • Dangelmaier CA, Quinter PG, Jin J, Tsygankov AY, Kunapuli SP, Daniel JL. 2005. Rapid ubiquitination of Syk following GPVI activation in platelets. Blood 105(10): 39183924.
  • Davies GC, Ettenberg SA, Coats AO, Mussante M, Ravichandran S, Collins J, Nau MM, Lipkowitz S. 2004. Cbl-b interacts with ubiquitinated proteins; differential functions of the UBA domains of c-Cbl and Cbl-b. Oncogene 23(42): 71047115.
  • de Bruyn KM, Rangarajan S, Reedquist KA, Figdor CG, Bos JL. 2002. The small GTPase Rap1 is required for Mn(2+)- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion. J Biol Chem 277(33): 2946829476.
  • de Melker AA, van Der Horst G, Calafat J, Jansen H, Borst J. 2001. c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J Cell Sci 114(Pt 11): 21672178.
  • de Melker AA, van der Horst G, Borst J. 2004a. c-Cbl directs EGF receptors into an endocytic pathway that involves the ubiquitin-interacting motif of Eps15. J Cell Sci 117(Pt 21): 50015012.
  • de Melker AA, van der Horst G, Borst J. 2004b. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. J Biol Chem 279(53): 5546555473.
  • Donovan JA, Wange RL, Langdon WY, Samelson LE. 1994. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 269(37): 2292122924.
  • Duan L, Miura Y, Dimri M, Majumder B, Dodge IL, Lakku Reddi A, Ghosh AK, Fernandes N, Zhou P, Mullane-Robinson K, Rao N, Donoghue S, Rogers RA, Bowtell D, Naramura M, Gu H, Band V, Band H. 2003. Cbl-mediated ubiquitinylation is required for lysosomal sorting of EGF receptor but is dispensable for endocytosis. J Biol Chem 278: 2895028960.
  • Duval M, Bedard-Goulet S, Delisle C, Gratton JP. 2003. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination: Consequences on nitric oxide production from endothelial cells. J Biol Chem 278(22): 2009120097.
  • Eichinger L, Pachebat JA, Glockner G, Rajandream MA, Sucgang R, Berriman M, Song J, Olsen R, Szafranski K, Xu Q, Tunggal B, Kummerfeld S, Madera M, Konfortov BA, Rivero F, Bankier AT, Lehmann R, Hamlin N, Davies R, Gaudet P, Fey P, Pilcher K, Chen G, Saunders D, Sodergren E, Davis P, Kerhornou A, Nie X, Hall N, Anjard C, Hemphill L, Bason N, Farbrother P, Desany B, Just E, Morio T, Rost R, Churcher C, Cooper J, Haydock S, van Driessche N, Cronin A, Goodhead I, Muzny D, Mourier T, Pain A, Lu M, Harper D, Lindsay R, Hauser H, James K, Quiles M, Madan Babu M, Saito T, Buchrieser C, Wardroper A, Felder M, Thangavelu M, Johnson D, Knights A, Loulseged H, Mungall K, Oliver K, Price C, Quail MA, Urushihara H, Hernandez J, Rabbinowitsch E, Steffen D, Sanders M, Ma J, Kohara Y, Sharp S, Simmonds M, Spiegler S, Tivey A, Sugano S, White B, Walker D, Woodward J, Winckler T, Tanaka Y, Shaulsky G, Schleicher M, Weinstock G, Rosenthal A, Cox EC, Chisholm RL, Gibbs R, Loomis WF, Platzer M, Kay RR, Williams J, Dear PH, Noegel AA, Barrell B, Kuspa A. 2005. The genome of the social amoeba Dictyostelium discoideum. Nature 435(7038): 4357.
  • Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J. 2001. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP- 65 signaling module. J Exp Med 194(3): 255264.
  • Erdreich-Epstein A, Liu M, Kant AM, Izadi KD, Nolta JA, Durden DL. 1999. Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages. J Leukoc Biol 65(4): 523534.
  • Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S. 1999. cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 18(10): 18551866.
  • Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, Yarden Y, Weissman AM, Lipkowitz S. 2001. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J Biol Chem 276(29): 2767727684.
  • Fang D, Liu YC. 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2(9): 870875.
  • Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC. 2000. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem 76: 872878.
  • Felsenfeld DP, Schwartzberg PL, Venegas A, Tse R, Sheetz MP. 1999. Selective regulation of integrin–cytoskeleton interactions by the tyrosine kinase Src. Nat Cell Biol 1(4): 200206.
  • Feshchenko EA, Langdon WY, Tsygankov AY. 1998. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J Biol Chem 273(14): 83238331.
  • Feshchenko EA, Shore SK, Tsygankov AY. 1999. Tyrosine phosphorylation of c-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of v-Abl-transformed NIH3T3 fibroblasts. Oncogene 18(25): 37033715.
  • Feshchenko EA, Smirnova EV, Swaminathan G, Teckchandani AM, Agrawal R, Band H, Zhang X, Annan RS, Carr SA, Tsygankov AY. 2004. TULA: An SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Oncogene 23(27): 46904706.
  • Finkelstein LD, Shimizu Y. 2000. Role of phosphoinositide 3-kinase and the Cbl adaptor protein in coupling the alpha4beta1 integrin to mitogen-activated protein kinase signalling. Biochem J 345(Pt 2): 385392.
  • Flanders JA, Feng Q, Bagrodia S, Laux MT, Singavarapu A, Cerione RA. 2003. The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins. FEBS Lett 550(1–3): 119123.
  • Fong CW, Leong HF, Wong ES, Lim J, Yusoff P, Guy GR. 2003. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. J Biol Chem 278(35): 3345633464.
  • Fukata M, Nakagawa M, Kaibuchi K. 2003. Roles of Rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol 15(5): 590597.
  • Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H. 1995. The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J Biol Chem 270(32): 1914119150.
  • Fukazawa T, Miyake S, Band V, Band H. 1996. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem 271(24): 1455414559.
  • Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J. 1995. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J Biol Chem 270(35): 2024220245.
  • Garcia-Guzman M, Larsen E, Vuori K. 2000. The proto-oncogene c-Cbl is a positive regulator of Met-induced MAP kinase activation: A role for the adaptor protein Crk. Oncogene 19(35): 40584065.
  • Gesbert F, Malarde V, Dautry-Varsat A. 2005. Ubiquitination of the common cytokine receptor gammac and regulation of expression by an ubiquitination/deubiquitination machinery. Biochem Biophys Res Commun 334(2): 474480.
  • Ghosh AK, Reddi AL, Rao NL, Duan L, Band V, Band H. 2004. Biochemical basis for the requirement of kinase activity for Cbl-dependent ubiquitinylation and degradation of a target tyrosine kinase. J Biol Chem 279(34): 3613236141.
  • Goh EL, Zhu T, Leong WY, Lobie PE. 2002. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription. Endocrinology 143(9): 35903603.
  • Griffiths EK, Sanchez O, Mill P, Krawczyk C, Hojilla CV, Rubin E, Nau MM, Khokha R, Lipkowitz S, Hui CC, Penninger JM. 2003. Cbl-3-deficient mice exhibit normal epithelial development. Mol Cell Biol 23(21): 77087718.
  • Grimsley CM, Kinchen JM, Tosello-Trampont AC, Brugnera E, Haney LB, Lu M, Chen Q, Klingele D, Hengartner MO, Ravichandran KS. 2004. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J Biol Chem 279(7): 60876097.
  • Grishin A, Sinha S, Roginskaya V, Boyer MJ, Gomez-Cambronero J, Zuo S, Kurosaki T, Romero G, Corey SJ. 2000. Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene 19(1): 97105.
  • Gronski MA, Boulter JM, Moskophidis D, Nguyen LT, Holmberg K, Elford AR, Deenick EK, Kim HO, Penninger JM, Odermatt B, Gallimore A, Gascoigne NR, Ohashi PS. 2004. TCR affinity and negative regulation limit autoimmunity. Nat Med 10(11): 12341239.
  • Grossmann AH, Kolibaba KS, Willis SG, Corbin AS, Langdon WS, Deininger MW, Druker BJ. 2004. Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl. FEBS Lett 577(3): 555562.
  • Grovdal LM, Stang E, Sorkin A, Madshus IH. 2004. Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation. Exp Cell Res 300(2): 388395.
  • Gur G, Rubin C, Katz M, Amit I, Citri A, Nilsson J, Amariglio N, Henriksson R, Rechavi G, Hedman H, Wides R, Yarden Y. 2004. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 23(16): 32703281.
  • Guy GR, Wong ES, Yusoff P, Chandramouli S, Lo TL, Lim J, Fong CW. 2003. Sprouty: How does the branch manager work? J Cell Sci 116(Pt 15): 30613068.
  • Haglund K, Shimokawa N, Szymkiewicz I, Dikic I. 2002. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc Natl Acad Sci USA 99(19): 1219112196.
  • Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I. 2003. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol 5(5): 461466.
  • Haglund K, Ivankovic-Dikic I, Shimokawa N, Kruh GD, Dikic I. 2004. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci 117(Pt 12): 25572568.
  • Haglund K, Schmidt MH, Wong ES, Guy GR, Dikic I. 2005. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep 6(7): 635641.
  • Hall AB, Jura N, DaSilva J, Jang YJ, Gong D, Bar-Sagi D. 2003. hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl. Curr Biol 13(4): 308314.
  • Hamilton E, Miller KM, Helm KM, Langdon WY, Anderson SM. 2001. Suppression of apoptosis induced by growth factor withdrawal by an oncogenic form of c-Cbl. J Biol Chem 276(12): 90289037.
  • Han JW, Lubyphelps K, Das B, Shu XD, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D. 1998. Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279(5350): 558560.
  • Hartley D, Corvera S. 1996. Formation of c-Cbl.phosphatidylinositol 3-kinase complexes on lymphocyte membranes by a p56lck-independent mechanism. J Biol Chem 271(36): 2193921943.
  • Hasegawa H, Kiyokawa E, Tanaka S, Nagashima K, Gotoh N, Shibuya M, Kurata T, Matsuda M. 1996. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 16(4): 17701776.
  • Heissmeyer V, Macian F, Im SH, Varma R, Feske S, Venuprasad K, Gu H, Liu YC, Dustin ML, Rao A. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 5(3): 255265.
  • Herndon TM, Pirone DM, Tsokos GC, Chen CS. 2005. T cell-to-T cell clustering enhances NF-kappaB activity by a PI3K signal mediated by Cbl-b and Rho. Biochem Biophys Res Commun 332: 11331139.
  • Hime GR, Dhungat MP, Ng A, Bowtell DD. 1997. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites. Oncogene 14(22): 27092719.
  • Hornstein I, Alcover A, Katzav S. 2004. Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16(1): 111.
  • Howlett CJ, Robbins SM. 2002. Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation. Oncogene 21(11): 17071716.
  • Howlett CJ, Bisson SA, Resek ME, Tigley AW, Robbins SM. 1999. The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase. Biochem Biophys Res Commun 257(1): 129138.
  • Hu J, Hubbard SR. 2005 . Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins. J Biol Chem 280(19): 1894318949.
  • Hu J, Liu J, Ghirlando R, Saltiel AR, Hubbard SR. 2003. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol Cell 12(6): 13791389.
  • Huang F, Sorkin A. 2005. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Mol Biol Cell 16(3): 12681281.
  • Hunter S, Burton EA, Wu SC, Anderson SM. 1999. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J Biol Chem 274(4): 20972106.
  • Izadi KD, Erdreich-Epstein A, Liu Y, Durden DL. 1998. Characterization of Cbl-Nck and Nck-Pak1 interactions in myeloid FcgammaRII signaling. Exp Cell Res 245(2): 330342.
  • Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, Bunnett NW. 2005. c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280(16): 1607616087.
  • JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A, Klip A. 2004. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol Endocrinol 18(2): 359372.
  • Jehn BM, Dittert I, Beyer S, von der Mark K, Bielke W. 2002. c-Cbl binding and ubiquitin-dependent lysosomal degradation of membrane-associated Notch1. J Biol Chem 277(10): 80338040.
  • Jeon MS, Atfield A, Venuprasad K, Krawczyk C, Sarao R, Elly C, Yang C, Arya S, Bachmaier K, Su L, Bouchard D, Jones R, Gronski M, Ohashi P, Wada T, Bloom D, Fathman CG, Liu YC, Penninger JM. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21(2): 167177.
  • Jiang X, Sorkin A. 2003. Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation. Traffic 4(8): 529543.
  • Jiang X, Huang F, Marusyk A, Sorkin A. 2003. Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14(3): 858870.
  • Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286(5438): 309312 [see comments].
  • Kaabeche K, Lemonnier J, Le Mee S, Caverzasio J, Marie PJ. 2004. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem 279(35): 3625936267.
  • Kaabeche K, Guenou H, Bouvard D, Didelot N, Listrat A, Marie PJ. 2005. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation. J Cell Sci 118(Pt 6): 12231232.
  • Kallies A, Rosenbauer F, Scheller M, Knobeloch KP, Horak I. 2002. Accumulation of c-Cbl and rapid termination of colony-stimulating factor 1 receptor signaling in interferon consensus sequence binding protein-deficient bone marrow-derived macrophages. Blood 99(9): 32133219.
  • Kant AM, De P, Peng X, Yi T, Rawlings DJ, Kim JS, Durden DL. 2002. SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC. Blood 100(5): 18521859.
  • Kassenbrock CK, Anderson SM. 2004. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J Biol Chem 279(27): 2801728027.
  • Kassenbrock CK, Hunter S, Garl P, Johnson GL, Anderson SM. 2002. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor. J Biol Chem 277(28): 2496724975.
  • Katagiri K, Hattori M, Minato N, Irie S, Takatsu K, Kinashi T. 2000. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 20(6): 19561969.
  • Katagiri K, Maeda A, Shimonaka M, Kinashi T. 2003. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 4(8): 741748.
  • Katagiri K, Ohnishi N, Kabashima K, Iyoda T, Takeda N, Shinkai Y, Inaba K, Kinashi T. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol 5(10): 10451051.
  • Katzmann DJ, Odorizzi G, Emr SD. 2002. Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3(12): 893905.
  • Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S. 1995. Cloning and characterization of cbl-b: A SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 10(12): 23672377.
  • Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S. 1999. cbl-3: A new mammalian cbl family protein. Oncogene 18(22): 33653375.
  • Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M, Yamamoto T. 1999. Molecular cloning and characterization of a novel cbl-family gene, cbl-c. Gene 239(1): 145154.
  • Kim M, Tezuka T, Tanaka K, Yamamoto T. 2004. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene 23(9): 16451655.
  • Kimura A, Baumann CA, Chiang SH, Saltiel AR. 2001. The sorbin homology domain: A motif for the targeting of proteins to lipid rafts. Proc Natl Acad Sci USA 98(16): 90989103.
  • Klapper LN, Waterman H, Sela M, Yarden Y. 2000. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res 60(13): 33843388.
  • Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA. 1998. CAS/Crk coupling serves as a “molecular switch” for induction of cell migration. J Cell Biol 140(4): 961972.
  • Kobayashi S, Sawano A, Nojima Y, Shibuya M, Maru Y. 2004. The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1). Faseb J 18(7): 929931.
  • Kowanetz K, Szymkiewicz I, Haglund K, Kowanetz M, Husnjak K, Taylor JD, Soubeyran P, Engstrom U, Ladbury JE, Dikic I. 2003. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. J Biol Chem 278(41): 3973539746.
  • Kowanetz K, Crosetto N, Haglund K, Schmidt MH, Heldin CH, Dikic I. 2004. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J Biol Chem 279(31): 3278632795.
  • Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308(5727): 14721477.
  • Krawczyk C, Bachmaier K, Sasaki T, Jones GR, Snapper BS, Bouchard D, Kozieradzki I, Ohashi SP, Alt WF, Penninger MJ. 2000. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13(4): 463473.
  • Krawczyk CM, Jones RG, Atfield A, Bachmaier K, Arya S, Odermatt B, Ohashi PS, Penninger JM. 2005. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b. J Immunol 174(3): 14721478.
  • Kurakin AV, Wu S, Bredesen DE. 2003. Atypical recognition consensus of CIN85/SETA/Ruk SH3 domains revealed by target-assisted iterative screening. J Biol Chem 278(36): 3410234109.
  • Kuwae A, Yoshida S, Tamano K, Mimuro H, Suzuki T, Sasakawa C. 2001. Shigella invasion of macrophage requires the insertion of IpaC into the host plasma membrane: Functional analysis of IpaC. J Biol Chem 276(34): 3207132079.
  • Kyo S, Sada K, Qu X, Maeno K, Miah SM, Kawauchi-Kamata K, Yamamura H. 2003. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc varepsilon RI-mediated mast cell activation. Genes Cells 8(10): 825836.
  • Lafont F, Simons K. 2001. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc Natl Acad Sci USA 98(6): 31803184.
  • Lafuente EM, van Puijenbroek AA, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB, Boussiotis VA. 2004. RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell 7(4): 585595.
  • Langdon W, Hartley J, Klinken S, Ruscetti S, Morse H. 1989a. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sci USA 86: 11681172.
  • Langdon W, Hyland C, Grumont R, Morse H. 1989b. The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J Virol 63(12): 54205424.
  • Langdon WY, Heath KG, Blake TJ. 1992. The localization of the products of the c-cbl and v-cbl oncogenes during mitosis and transformation. Curr Top Microbiol Immunol 182: 467474.
  • Lazaar AL, Krymskaya VP, Das SK. 2001. VCAM-1 activates phosphatidylinositol 3-kinase and induces p120(Cbl) phosphorylation in human airway smooth muscle cells. J Immunol 166(1): 155161.
  • Lee PSW, Wang Y, Dominguez MG, Yeung YG, Murphy MA, Bowtell DDL, Stanley ER. 1999. The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J 18(13): 36163628.
  • Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M, Yarden Y. 1996. Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene 12(5): 11171125.
  • Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y. 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 12(23): 36633674.
  • Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 4(6): 10291040.
  • Levkowitz G, Oved S, Klapper LN, Harari D, Lavi S, Sela M, Yarden Y. 2000. c-Cbl is a suppressor of the neu oncogene. J Biol Chem 275(45): 3553235539.
  • Li L, Okura M, Imamoto A. 2002. Focal adhesions require catalytic activity of SRC family kinases to mediate integrin-matrix adhesion. Mol Cell Biol 22(4): 12031217.
  • Li D, Gal I, Vermes C, Alegre ML, Chong AS, Chen L, Shao Q, Adarichev V, Xu X, Koreny T, Mikecz K, Finnegan A, Glant TT, Zhang J. 2004. Cutting edge: Cbl-b: One of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol 173(12): 71357139.
  • Liang Y, Kurakin A, Roizman B. 2005. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces. Proc Natl Acad Sci USA 102(16): 58385843.
  • Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML, Jr., Miyake S, Meissner-Lula N, Hsu VW, Band H. 2000. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J Biol Chem 275(1): 367377.
  • Liu YC, Liu Y, Elly C, Yoshida H, Lipkowitz S, Altman A. 1997. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif. J Biol Chem 272(15): 99799985.
  • Liu Y, Liu YC, Meller N, Giampa L, Elly C, Doyle M, Altman A. 1999. Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins. J Immunol 162(12): 70957101.
  • Liu J, Kimura A, Baumann CA, Saltiel AR. 2002a. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol 22(11): 35993609.
  • Liu L, Schwartz BR, Tupper J, Lin N, Winn RK, Harlan JM. 2002b. The GTPase Rap1 regulates phorbol 12-myristate 13-acetate-stimulated but not ligand-induced beta 1 integrin-dependent leukocyte adhesion. J Biol Chem 277(43): 4089340900.
  • Liu J, DeYoung SM, Hwang JB, O'Leary EE, Saltiel AR. 2003. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J Biol Chem 278(38): 3675436762.
  • Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. 2002. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol 156(5): 843854.
  • Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Barsagi D, Schlessinger J. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to Ras signaling. Cell 70(3): 431442.
  • Lupher ML, Jr., Songyang Z, Shoelson SE, Cantley LC, Band H. 1997. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem 272(52): 3314033144.
  • Lupher ML, Jr., Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H. 1998. Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem 273(52): 3527335281.
  • Lynch DK, Winata S, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ. 2003. A cortactin/CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J Biol Chem 2: 2.
  • Macglashan D, Miura K. 2004. Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 114(6): 13171324.
  • Magnan A, Di Bartolo V, Mura AM, Boyer C, Richelme M, Lin YL, Roure A, Gillet A, Arrieumerlou C, Acuto O, Malissen B, Malissen M. 2001. T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase. J Exp Med 194(4): 491505.
  • Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S, Lipkowitz S, Weissman AM. 2003. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem 278(44): 4316943177.
  • Mancini A, Koch A, Wilms R, Tamura T. 2002. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms. J Biol Chem 277(17): 1463514640.
  • Marengere LE, Mirtsos C, Kozieradzki I, Veillette A, Mak TW, Penninger JM. 1997. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells. J Immunol 159(1): 7076.
  • Martinez JJ, Seveau S, Veiga E, Matsuyama S, Cossart P. 2005. Ku70, a Component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell 123(6): 10131023.
  • Mason JM, Morrison DJ, Bassit B, Dimri M, Band H, Licht JD, Gross I. 2004. Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: A dual feedback loop. Mol Biol Cell 15(5): 21762188.
  • Meisner H, Czech MP. 1995. Coupling of the proto-oncogene product c-Cbl to the epidermal growth factor receptor. J Biol Chem 270(43): 2533225335.
  • Meisner H, Conway BR, Hartley D, Czech MP. 1995. Interactions of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat cells. Mol Cell Biol 15(7): 35713578.
  • Melander F, Andersson T, Dib K. 2003. Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils. Biochem J 370(Pt 2): 687694.
  • Melander F, Andersson T, Dib K. 2004. Engagement of beta2 integrins recruits 14-3-3 proteins to c-Cbl in human neutrophils. Biochem Biophys Res Commun 317(4): 10001005.
  • Meng F, Lowell CA. 1998. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. EMBO Journal 17(15): 43914403.
  • Meng W, Sawasdikosol S, Burakoff SJ, Eck MJ. 1999. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398(6722): 8490.
  • Mertens AE, Roovers RC, Collard JG. 2003. Regulation of Tiam1-Rac signalling. FEBS Lett 546(1): 1116.
  • Miao H, Yuan S, Wang Y, Tsygankov A, Chien S. 2002. Role of Cbl in shear-activation of PI 3-kinase and JNK in endothelial cells. Biochem Biophys Res Commun 292(4): 892899.
  • Minami A, Iseki M, Kishi K, Wang M, Ogura M, Furukawa N, Hayashi S, Yamada M, Obata T, Takeshita Y, Nakaya Y, Bando Y, Izumi K, Moodie SA, Kajiura F, Matsumoto M, Takatsu K, Takaki S, Ebina Y. 2003. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 52(11): 26572665.
  • Missy K, Van Poucke V, Raynal P, Viala C, Mauco G, Plantavid M, Chap H, Payrastre B. 1998. Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation. J Biol Chem 273(46): 3027930286.
  • Mitra P, Zheng X, Czech MP. 2004. RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. J Biol Chem 279(36): 3743137435.
  • Miura A, Sajan MP, Standaert ML, Bandyopadhyay G, Franklin DM, Lea-Currie R, Farese RV. 2003. Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes. Biochemistry 42(48): 1433514341.
  • Miura A, Sajan MP, Standaert ML, Bandyopadhyay G, Kahn CR, Farese RV. 2004. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes. Biochemistry 43(49): 1550315509.
  • Miura-Shimura Y, Duan L, Rao NL, Reddi AL, Shimura H, Rottapel R, Druker BJ, Tsygankov A, Band V, Band H. 2003. Cbl-mediated ubiquitinylation and negative regulation of Vav. J Biol Chem 278(40): 3849538504.
  • Miyake S, Mullane-Robinson KP, Lill NL, Douillard P, Band H. 1999. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain. J Biol Chem 274(23): 1661916628.
  • Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC, Baron R. 2004. Src kinase activity is essential for osteoclast function. J Biol Chem 279(17): 1766017666.
  • Molero JC, Jensen TE, Withers PC, Couzens M, Herzog H, Thien CB, Langdon WY, Walder K, Murphy MA, Bowtell DD, James DE, Cooney GJ. 2004. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest 114(9): 13261333.
  • Morrison AC, Wilson CB, Ray M, Correll PH. 2004. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 172(3): 18251832.
  • Mosesson Y, Shtiegman K, Katz M, Zwang Y, Vereb G, Szollosi J, Yarden Y. 2003. Endocytsosis of receptor tyrosine kinases is driven by mono-, not poly-ubiquitylation. J Biol Chem 278: 2132321326.
  • Motegi A, Fujimoto J, Kotani M, Sakuraba H, Yamamoto T. 2004. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci 117(Pt 15): 33193329.
  • Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB, Langdon WY, Bowtell DD. 1998. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 18(8): 48724882.
  • Nakagawa H, Miki H, Ito M, Ohashi K, Takenawa T, Miyamoto S. 2001. N-WASP, WAVE and Mena play different roles in the organization of actin cytoskeleton in lamellipodia. J Cell Sci 114(Pt 8): 15551565.
  • Nakashima N, Rose DW, Xiao S, Egawa K, Martin SS, Haruta T, Saltiel AR, Olefsky JM. 1999. The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J Biol Chem 274(5): 30013008.
  • Naramura M, Kole HK, Hu RJ, Gu H. 1998. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA 95(26): 1554715552.
  • Naramura M, Jang IK, Kole H, Huang F, Haines D, Gu H. 2002. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol 3(12): 11921199.
  • Nau MM, Lipkowitz S. 2003. Comparative genomic organization of the cbl genes. Gene 308: 103113.
  • Niederberger N, Holmberg K, Alam SM, Sakati W, Naramura M, Gu H, Gascoigne NR. 2003. Allelic exclusion of the TCR alpha-chain is an active process requiring TCR-mediated signaling and c-Cbl. J Immunol 170(9): 45574563.
  • Nikawa T, Ishidoh K, Hirasaka K, Ishihara I, Ikemoto M, Kano M, Kominami E, Nonaka I, Ogawa T, Adams GR, Baldwin KM, Yasui N, Kishi K, Takeda S. 2004. Skeletal muscle gene expression in space-flown rats. FASEB J 18(3): 522524.
  • Nishio H, Otsuka M, Kinoshita S, Tokuoka T, Nakajima M, Noda Y, Fukuyama Y, Suzuki K. 2002. Phosphorylation of c-Cbl protooncogene product following ethanol administration in rat cerebellum: Possible involvement of Fyn kinase. Brain Res 950(1–2): 203209.
  • Nusser N, Gosmanova E, Zheng Y, Tigyi G. 2002. Nerve growth factor signals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 cells. J Biol Chem 277(39): 3584035846.
  • Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y, Hirai H. 1995. The proto-oncogene product c-Cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem 270(18): 1080010805.
  • Ohrt T, Mancini A, Tamura T, Niedenthal R. 2004. c-Cbl binds to tyrosine-phosphorylated neurotrophin receptor p75 and induces its ubiquitination. Cell Signal 16(11): 12911298.
  • Ojaniemi M, Martin SS, Dolfi F, Olefsky JM, Vuori K. 1997. The proto-oncogene product p120(cbl) links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway. J Biol Chem 272(6): 37803787.
  • Ojaniemi M, Langdon WY, Vuori K. 1998. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation. Oncogene 16(24): 31593167.
  • Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, Langdon WY. 2003. Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor. Oncogene 22(52): 85098518.
  • Okuda K, Sato Y, Sonoda Y, Griffin JD. 2004. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors. Int J Hematol 79(2): 138146.
  • Ota S, Hazeki K, Rao N, Lupher ML, Jr., Andoniou CE, Druker B, Band H. 2000. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 275(1): 414422.
  • Panigada M, Porcellini S, Barbier E, Hoeflinger S, Cazenave PA, Gu H, Band H, von Boehmer H, Grassi F. 2002. Constitutive endocytosis and degradation of the pre-T cell receptor. J Exp Med 195(12): 15851597.
  • Paolini R, Molfetta R, Beitz LO, Zhang J, Scharenberg AM, Piccoli M, Frati L, Siraganian R, Santoni A. 2002. Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells. J Biol Chem 277(40): 3694036947.
  • Park RK, Izadi KD, Deo YM, Durden DL. 1999. Role of Src in the modulation of multiple adaptor proteins in FcalphaRI oxidant signaling. Blood 94(6): 21122120.
  • Pedraza-Alva G, Sawasdikosol S, Liu YC, Merida LB, Cruz-Munoz ME, Oceguera-Yanez F, Burakoff SJ, Rosenstein Y. 2001. Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells. J Biol Chem 276(1): 729737.
  • Penengo L, Rubin C, Yarden Y, Gaudino G. 2003. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene 22(24): 36693679.
  • Peschard P, Park M. 2003. Escape from Cbl-mediated downregulation: A recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 3(6): 519523.
  • Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M. 2004. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem 279(28): 2956529571.
  • Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. 2002. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416(6877): 187190.
  • Qu X, Sada K, Kyo S, Maeno K, Miah SM, Yamamura H. 2004. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b. Blood 103(5): 17791786.
  • Raftopoulou M, Hall A. 2004. Cell migration: Rho GTPases lead the way. Dev Biol 265(1): 2332.
  • Rao N, Lupher ML, Ota S, Reedquist KA, Druker BJ, Band H. 2000. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol 164(9): 46164626.
  • Rao N, Ghosh AK, Ota S, Zhou P, Reddi AL, Hakezi K, Druker BK, Wu J, Band H. 2001. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J 20(24): 70857095.
  • Rao N, Miyake S, Reddi AL, Douillard P, Ghosh AK, Dodge IL, Zhou P, Fernandes ND, Band H. 2002. Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci USA 99(6): 37943799.
  • Ravid T, Heidinger JM, Gee P, Khan EM, Goldkorn T. 2004. c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. J Biol Chem 279(35): 3715337162.
  • Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD, Bos JL. 2000. The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 148(6): 11511158.
  • Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR. 1998. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol Cell Biol 18(2): 872879.
  • Robertson H, Hime GR, Lada H, Bowtell DD. 2000. A Drosophila analogue of v-Cbl is a dominant-negative oncoprotein in vivo. Oncogene 19(29): 32993308.
  • Rohde CM, Schrum J, Lee AW. 2004. A juxtamembrane tyrosine in the colony stimulating factor-1 receptor regulates ligand-induced Src association, receptor kinase function, and down-regulation. J Biol Chem 279(42): 4344843461.
  • Rubin C, Litvak V, Medvedovsky H, Zwang Y, Lev S, Yarden Y. 2003. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr Biol 13(4): 297307.
  • Rubin C, Gur G, Yarden Y. 2005. Negative regulation of receptor tyrosine kinases: Unexpected links to c-Cbl and receptor ubiquitylation. Cell Res 15(1): 6671.
  • Sada K, Zhang J, Siraganian RP. 2000. Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 164(1): 338344.
  • Salomon AR, Ficarro SB, Brill LM, Brinker A, Phung QT, Ericson C, Sauer K, Brock A, Horn DM, Schultz PG, Peters EC. 2003. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 100(2): 443448.
  • Samet JM, Dewar BJ, Wu W, Graves LM. 2003. Mechanisms of Zn(2+)-induced signal initiation through the epidermal growth factor receptor. Toxicol Appl Pharmacol 191(1): 8693.
  • Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, Baron R. 2001. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152(1): 181196.
  • Sato N, Kim MK, Schreiber AD. 1999. Enhancement of fcgamma receptor-mediated phagocytosis by transforming mutants of Cbl. J Immunol 163(11): 61236131.
  • Scaife RM, Langdon WY. 2000. c-Cbl localizes to actin lamellae and regulates lamellipodia formation and cell morphology. J Cell Sci 113(Pt 2): 215226.
  • Scaife RM, Courtneidge SA, Langdon WY. 2003a. The multi-adaptor proto-oncoprotein Cbl is a key regulator of Rac and actin assembly. J Cell Sci 116(Pt 3): 463473.
  • Scaife RM, Job D, Langdon WY. 2003b. Rapid microtubule-dependent induction of neurite-like extensions in NIH 3T3 fibroblasts by inhibition of ROCK and Cbl. Mol Biol Cell 14(11): 46054617.
  • Schmidt MH, Dikic I. 2005. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 6: 907919.
  • Scholz G, Cartledge K, Dunn AR. 2000. Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cbl and phosphatidylinositol 3-kinase. J Biol Chem 275(19): 1461514623.
  • Schuebel KE, Movilla N, Rosa JL, Bustelo XR. 1998. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J 17(22): 66086621.
  • Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE. 1997. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src−/− mutant mice. Genes Dev 11(21): 28352844.
  • Scott RP, Eketjall S, Aineskog H, Ibanez CF. 2005. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase. J Biol Chem 280(14): 1344213449.
  • Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. 2002. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat Immunol 3(3): 251258.
  • Shao Y, Elly C, Liu YC. 2003. Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase. EMBO Rep 4(4): 425431.
  • Shao Y, Yang C, Elly C, Liu YC. 2004. Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl. J Biol Chem 279(42): 4364643653.
  • Sharfe N, Freywald A, Toro A, Roifman CM. 2003. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol 170(12): 60246032.
  • Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ. 2001. Suppression of apoptosis and granulocyte colony-stimulating factor- induced differentiation by an oncogenic form of Cbl. Exp Hematol 29(6): 746755.
  • Sohn HW, Gu H, Pierce SK. 2003. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J Exp Med 197(11): 15111524.
  • Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64(4): 693702.
  • Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416(6877): 183187.
  • Soubeyran P, Barac A, Szymkiewicz I, Dikic I. 2003. Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl. Biochem J 370(Pt 1): 2934.
  • Standaert ML, Sajan MP, Miura A, Bandyopadhyay G, Farese RV. 2004. Requirements for pYXXM motifs in Cbl for binding to the p85 subunit of phosphatidylinositol 3-kinase and Crk, and activation of atypical protein kinase C and glucose transport during insulin action in 3T3/L1 adipocytes. Biochemistry 43(49): 1549415502.
  • Stang E, Blystad FD, Kazazic M, Bertelsen V, Brodahl T, Raiborg C, Stenmark H, Madshus IH. 2004. Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits. Mol Biol Cell 15(8): 35913604.
  • Steen H, Kuster B, Fernandez M, Pandey A, Mann M. 2002. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J Biol Chem 277(2): 10311039.
  • Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I. 2002. CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem 277(42): 3966639672.
  • Taher TE, Tjin EP, Beuling EA, Borst J, Spaargaren M, Pals ST. 2002. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J Immunol 169(7): 37933800.
  • Takayama Y, May P, Anderson RG, Herz J. 2005. Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFRbeta). J Biol Chem 280(18): 1850418510.
  • Take H, Watanabe S, Takeda K, Yu ZX, Iwata N, Kajigaya S. 2000. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun 268(2): 321328.
  • Tanaka S, Neff L, Baron R, Levy JB. 1995. Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem 270(24): 1434714351.
  • Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R. 1996. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383(6600): 528531.
  • Tang J, Sawasdikosol S, Chang JH, Burakoff SJ. 1999. SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. Proc NA Sci USA 96(17): 97759780.
  • Teckchandani AM, Feshchenko EA, Tsygankov AY. 2001. c-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene 20(14): 17391755.
  • Teckchandani AM, Birukova AA, Tar K, Verin AD, Tsygankov AY. 2005a. The multidomain protooncogenic protein c-Cbl binds to tubulin and stabilizes microtubules. Exp Cell Res 306(1): 114127.
  • Teckchandani AM, Panetti TS, Tsygankov AY. 2005b. c-Cbl regulates migration of v-Abl-transformed NIH 3T3 fibroblasts via Rac1. Exp Cell Res 307(1): 247258.
  • Thien CB, Langdon WY. 1997a. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene 14(18): 22392249.
  • Thien CB, Langdon WY. 1997b. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 15(24): 29092919.
  • Thien CB, Bowtell DD, Langdon WY. 1999. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes. J Immunol 162(12): 71337139.
  • Thien CB, Walker F, Langdon WY. 2001. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol Cell 7(2): 355365.
  • Thien CB, Scaife RM, Papadimitriou JM, Murphy MA, Bowtell DD, Langdon WY. 2003. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase. J Exp Med 197(4): 503513.
  • Thien CB, Blystad FD, Zhan Y, Lew AM, Voigt V, Andoniou CE, Langdon WY. 2005. Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion. EMBO J 24(21): 38073819.
  • Thirone AC, Carvalheira JB, Hirata AE, Velloso LA, Saad MJ. 2004. Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance. Endocrinology 145(1): 281293.
  • Tietzel I, Mosser DM. 2002. The modulation of macrophage activation by tyrosine phosphorylation. Front Biosci 7: d1494d1502.
  • Timpson P, Lynch DK, Schramek D, Walker F, Daly RJ. 2005. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res 65(8): 32733280.
  • Tohyama Y, Katagiri K, Pardi R, Lu C, Springer TA, Kinashi T. 2003. The critical cytoplasmic regions of the alphaL/beta2 integrin in Rap1-induced adhesion and migration. Mol Biol Cell 14(6): 25702582.
  • Tsukamoto N, Hattori M, Yang H, Bos JL, Minato N. 1999. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem 274(26): 1846318469.
  • Tsutsui S, Noorbakhsh F, Sullivan A, Henderson AJ, Warren K, Toney-Earley K, Waltz SE, Power C. 2005. RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Ann Neurol 57(6): 883895.
  • Tsygankov AY, Teckchandani AM, Feshchenko EA, Swaminathan G. 2001 . Beyond the RING: CBL proteins as multivalent adapters. Oncogene 20(44): 63826402.
  • Uemura N, Griffin JD. 1999. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem 274(53): 3752537532.
  • Uemura N, Salgia R, Ewaniuk DS, Little MT, Griffin JD. 1999. Involvement of the adapter protein CRKL in integrin-mediated adhesion. Oncogene 18(22): 33433353.
  • Veiga E, Cossart P. 2005. Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat Cell Biol 7(9): 894900.
  • Verdier F, Valovka T, Zhyvoloup A, Drobot LB, Buchman V, Waterfield M, Gout I. 2002. Ruk is ubiquitinated but not degraded by the proteasome. Eur J Biochem 269(14): 34023408.
  • Walker-Daniels J, Riese DJ, II, Kinch MS. 2002. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res 1(1): 7987.
  • Wang Y, Yeung YG, Stanley ER. 1999. CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins. J Cell Biochem 72(1): 119134.
  • Wang HY, Altman Y, Fang D, Elly C, Dai Y, Shao Y, Liu YC. 2001. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem 276(28): 2600426011.
  • Wang L, Rudert WA, Loutaev I, Roginskaya V, Corey SJ. 2002a. Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene 21(34): 53465355.
  • Wang Y, Miao H, Li S, Chen KD, Li YS, Yuan S, Shyy JY, Chien S. 2002b. Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol 283(5): C1540C1547.
  • Wang Y, Ota S, Kataoka H, Kanamori M, Li Z, Band H, Tanaka M, Sugimura H. 2002c. Negative regulation of EphA2 receptor by Cbl. Biochem Biophys Res Commun 296(1): 214220.
  • Wang Y, Chang J, Li YC, Li YS, Shyy JY, Chien S. 2004. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 286(2): H685H692.
  • Waterman H, Levkowitz G, Alroy I, Yarden Y. 1999. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J Biol Chem 274(32): 2215122154.
  • Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T, Yarden Y. 2002. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. EMBO J 21(3): 303313.
  • Wiedemann A, Muller S, Favier B, Penna D, Guiraud M, Delmas C, Champagne E, Valitutti S. 2005. T-cell activation is accompanied by an ubiquitination process occurring at the immunological synapse. Immunol Lett 98(1): 5761.
  • Wilhelmsen K, Burkhalter S, van der Geer P. 2002. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene 21(7): 10791089.
  • Wilkinson CR, Seeger M, Hartmann-Petersen R, Stone M, Wallace M, Semple C, Gordon C. 2001. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol 3(10): 939943.
  • Wohlfert EA, Callahan MK, Clark RB. 2004. Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b−/− mice. J Immunol 173(2): 10591065.
  • Wong A, Lamothe B, Lee A, Schlessinger J, Lax I. 2002a. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci USA 99(10): 66846689.
  • Wong ES, Fong CW, Lim J, Yusoff P, Low BC, Langdon WY, Guy GR. 2002b. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J 21(18): 47964808.
  • Wozniak MA, Modzelewska K, Kwong L, Keely PJ. 2004. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 1692(2–3): 103119.
  • Wu WJ, Tu S, Cerione RA. 2003. Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell 114(6): 715725.
  • Xiong H, Li H, Kong HJ, Chen Y, Zhao J, Xiong S, Huang B, Gu H, Mayer L, Ozato K, Unkeless JC. 2005. Ubiquitin-dependent degradation of IRF-8 mediated by Cbl down-regulates IL-12 expression. J Biol Chem 80: 35313539.
  • Xu H, Littman DR. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell 74(4): 633643.
  • Xu Z, George C, Jolly CA. 2004. CD28 activation does not down-regulate Cbl-b expression in aged rat T-lymphocytes. Mech Ageing Dev 125(9): 595602.
  • Yang P, Henderson AJ. 2005. Nef enhances c-Cbl phosphorylation in HIV-infected CD4(+) T lymphocytes. Virology 336(2): 219228.
  • Yasuda T, Maeda A, Kurosaki M, Tezuka T, Hironaka K, Yamamoto T, Kurosaki T. 2000. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-gamma2 activation by regulating B cell linker protein-PLC-gamma2 binding. J Exp Med 191(4): 641650.
  • Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, Kurosaki T, Yamamoto T. 2002. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells. J Exp Med 196(1): 5163.
  • Yeung YG, Wang Y, Einstein DB, Lee PS, Stanley ER. 1998. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. J Biol Chem 273(27): 1712817137.
  • Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y, Seino Y, Yasuda K, Serikawa T, Seino S. 2002. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 31(4): 391394.
  • Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R. 1999. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 274(44): 3170731712.
  • Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, Baron R. 2001. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem 276: 3518535193.
  • Yoon CH, Lee J, Jongeward GD, Sternberg PW. 1995. Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269(5227): 11021105.
  • Zell T, Warden CS, Chan AS, Cook ME, Dell CL, Hunt SW, III, Shimizu Y. 1998. Regulation of beta 1-integrin-mediated cell adhesion by the Cbl adaptor protein. Curr Biol 8(14): 814822.
  • Zeng S, Xu Z, Lipkowitz S, Longley JB. 2005. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood 105(1): 226232.
  • Zhang Z, Elly C, Qiu L, Altman A, Liu YC. 1999. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells. Curr Biol 9(4): 203206.
  • Zhang J, Bardos T, Li D, Gal I, Vermes C, Xu J, Mikecz K, Finnegan A, Lipkowitz S, Glant TT. 2002. Cutting edge: Regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J Immunol 169(5): 22362240.
  • Zhang W, Shao Y, Fang D, Huang J, Jeon MS, Liu YC. 2003. Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J Biol Chem 278(26): 2397823983.
  • Zhang J, Chiang YJ, Hodes RJ, Siraganian RP. 2004. Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J Immunol 173(3): 18111818.
  • Zhang B, Srirangam A, Potter DA, Roman A. 2005. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24(15): 25852588.
  • Zheng N, Wang P, Jeffrey PD, Pavletich NP. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102(4): 533539.
  • Zvara A, Fajardo JE, Escalante M, Cotton G, Muir T, Kirsch KH, Birge RB. 2001. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene 20(8): 951961.